Algocyte brings more blood monitoring into the patient's home under clinical supervision, supporting pathways by generating more data between appointments.
Patients must attend frequent in-person testing appointments to stay on clozapine with little data available between appointments.
Monitoring requirements create the single biggest barriers to proper treatment.
Testing, follow-up and treatment management live in separate systems.
Traditional pathways are resource-intensive and hard to expand.
Algocyte Proxima is minimally invasive and retrieves results in about 20 minutes. Automated reminders and longitudinal monitoring keep patients engaged.
Meet Algocyte® Proxima™
AI-driven longitudinal monitoring surfaces patients trending toward neutropenia early, so escalation decisions happen on signal generated by more regular longitudinal testing, in addition to current testing.
Inside HealthHubCo-design the pathway with your healthcare professionals.
Potential LIMS integration capability to route alerts.
Devices can operate at home under professional supervision.
Longitudinal trends are generated producing more data for better decision support.
Personal health intelligence, in one place you control.
Learn moreOncology pathways and dashboards with LIMS integration capabilities in development.
Learn moreOutcome data for value-based contracts and lower spend.
Learn moreSponsor-supported oncology and decentralized trials.
Learn moreSee Algocyte in action.
